We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BRI2 Inhibits Amyloid β-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate.
- Authors
Matsuda, Shuji; Giliberto, Luca; Matsuda, Yukiko; McGowan, Eileen M.; D'Adamio, Luciano
- Abstract
Genetic alterations of amyloid β-peptide (Aβ) production caused by mutations in the Aβ precursor protein (APP) cause familial Alzheimer's disease (AD). Mutations in BRI2, a gene of undefined function, are linked to familial British and Danish dementias, which are pathologically and clinically similar to Alzheimer's disease. We report that BRI2 is a physiological suppressor of Aβ production. BRI2 restrict docking of γ-secretase to APP and access of α- and β-secretases to their cleavage APP sequences. Alterations of BRI2 by gene targeting or transgenic expression regulate Aβ levels and AD pathology in mouse models of AD. Competitive inhibition of APP processing by BRI2 may provide a new approach to AD therapy and prevention.
- Subjects
ALZHEIMER'S disease; PRESENILE dementia; PATHOLOGY; GENETIC engineering; PREVENTIVE medicine; HUNTINGTON disease
- Publication
Journal of Neuroscience, 2008, Vol 28, Issue 35, p8668
- ISSN
0270-6474
- Publication type
Article
- DOI
10.1523/JNEUROSCI.2094-08.2008